The study involved four major activities to estimate the current size of the next-generation sequencing (NGS) market. Figure 29 Key Developments in the Next-Generation Sequencing Market, 2016–2019 Figure 30 Illumina Held the Leading Position in the Next-Generation Sequencing Market as of 2018 Defend your Market Share or Win Competitors. How will the use of NGS in diagnostics impact the overall adoption and industry of NGS products? You can change your choices at any time by visiting Your Privacy Controls. Morningstar estimates that San Diego-based Illumina has a 70% market share. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. Illumina (NASDAQ:ILMN) is a … An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the NGS market. *Business Overview, Products and Services Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. Zistite viac o tom, ako používame vaše informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie. Fiscal Year 2019 GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.07 - $6.17 Amortization of acquired intangible assets 0.24 Non-cash interest expense (b) 0.33 Incremental non-GAAP tax expense (c) (0.14) Non-GAAP diluted earnings per share attributable to Illumina stockholders (… On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. - 95)    9.1 Introduction     9.2 Academic Institutes & Research Centers            9.2.1 Development of Cost-Effective NGS Products & Services for Researchers to Propel Market Growth    9.3 Pharmaceutical & Biotechnology Companies            9.3.1 Growing Agreements & Collaborations Between Next-Generation Sequencing Market Players and Pharma Biotech Firms to Fuel Market Growth    9.4 Hospitals & Clinics            9.4.1 Development of Advanced NGS-Based Diagnostic Solutions to Enhance the Adoption of NGS in Hospitals & Clinics    9.5 Other End Users, 10 Next-Generation Sequencing Market, By Region (Page No. In terms of market share, China closely followed Japan in 2019. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. These methods were also used extensively to estimate the size of various subsegments in the market. Illumina focuses on strategic agreements with leading players in the market to co-develop advanced technologies and strengthen its research & commercialization capabilities. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Both top-down and bottom-up approaches were employed to estimate the complete market size. - 20)    1.1 Objectives of the Study     1.2 Market Definition     1.3 Market Scope            1.3.1 Markets Covered           1.3.2 Years Considered for the Study    1.4 Currency     1.5 Limitations     1.6 Stakeholders, 2 Research Methodology (Page No. Thermo Fisher Scientific (US) offers sequencers that run on its Ion semiconductor technology (the second-largest segment of the technologies market). Illumina’s products include a wide range of sequencing, genotyping, gene expression, molecular diagnostic platforms, consumables, and services. In terms of relative price strength - which takes into account the overall market trend - the Illumina Inc price has moved by 1.29% over the past year. The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research. Shares in Illumina Inc are currently trading at $376.35 and the price has moved by 15.46% over the past 365 days. 3. Industry Trends. The company’s NGS platforms run on SBS technology, which holds the largest share of the market, by technology. Where will the advancements in products offered by various companies take the industry in the mid- to long-term? The report contains data of the base year 2018 and historic year 2017. Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. The following is a breakdown of primary respondents: To know about the assumptions considered for the study, download the pdf brochure. 80% of fortune 2000 companies rely on our research to identify new revenue sources. FOCUS ON SELECT PLAYERS . Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. Over the past three years, Illumina has launched several products in the market. SAN DIEGO--(BUSINESS WIRE)--Jul. - 77)    7.1 Introduction     7.2 Sequencing By Synthesis            7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time    7.3 ION Semiconductor Sequencing            7.3.1 ION Semiconductor Sequencing Platforms Possess High-Throughput Capabilities    7.4 Single-Molecule Real-Time Sequencing            7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs    7.5 Nanopore Sequencing            7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct Rna Sequencing Capabilities    7.6 Other Sequencing Technologies, 8 Next-Generation Sequencing Market, By Application (Page No. The news follows Illumina shares … Yesterday, genome-sequencing company Illumina reported its second-quarter earnings results after the market closed. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. Global top 2000 strategist rely on us for their growth strategies. - 38)    4.1 Next-Generation Sequencing Market Overview     4.2 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)     4.3 Next-Generation Sequencing Market Share, By Technology, 2019 vs 2025     4.4 Next-Generation Sequencing Market, By Application, 2019 vs 2025 (USD Million)     4.5 Next-Generation Sequencing Market, By End User, 2019 vs 2025 (USD Million)     4.6 Next-Generation Sequencing Market: Geographical Snapshot, 5 Market Overview (Page No. The key players in the industry and markets have been identified through extensive secondary research. The company also offers reagents & consumables, software, and services for NGS research. Illumina Inc. (NASDAQ: ILMN) beat analysts’ forecasts for revenue and earnings in the second quarter of 2019. The demand side of this market is characterized by the significant use of NGS platforms due to factors such as advancements and declining costs in NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. [227 Pages Report] The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%., at a CAGR of 20.9%. Global Cancer Diagnostics Market… ILLUMINA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ILLUMINA, INC. Stock | ILMN | Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for the growth of this market. At Friday’s close, the price has more than doubled, to $311.15, up $2.05 for the day. Despite the beat, shares were down 2.9% in after-market hours on Monday. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. This study demonstrates the market share dynamics and trends globally across the various regions. Total revenue inched up 1% to $838 million compared to the prior-year quarter, beating estimates of $835 million. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. Global microbiome sequencing market is expected to rise to an estimated value of USD 3455.33 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026.This rise in market value can be attributed to the focus of various researchers on utilization of this technology in the development of personalized medicine and dietary applications. 11, 2019--Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance. Who will be your Top Customer; what will make them switch? In 2018, the SBS segment accounted for the largest share of the NGS market. Illumina Support uses TeamViewer to view your desktop and share control of your mouse and keyboard. All of these factors should enable Illumina to increase its revenue in 2019 by 13% to 14% and its adjusted earnings per share (EPS) by close to 15%, … Illumina CEO Francis deSouza noted to investors that his company is now taking a "cautious view" of the opportunity in the near term, referring to the market for ancestry and health tests. Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. - 218)     13.1 Discussion Guide      13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal      13.3 Available Customizations      13.4 Related Reports      13.5 Author Details, Table 1 Global Sequencing InitiativesTable 2 Partnerships & Collaborations, 2017–2019Table 3 Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 4 Presequencing Products & Services Market, By Region, 2017–2025 (USD Million)Table 5 Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 6 Library Preparation & Target Enrichment Market, By Region, 2017–2025 (USD Million)Table 7 Quality Control Market, By Region, 2017–2025 (USD Million)Table 8 NGS Consumables Market, By Region, 2017–2025 (USD Million)Table 9 NGS Platforms Market, By Type, 2017–2025 (USD Million)Table 10 NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 11 Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 12 Illumina NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 13 Hiseq Systems Market, By Region, 2017–2025 (USD Million)Table 14 Hiseq X Ten & Hiseq X Five Market, By Region, 2017–2025 (USD Million)Table 15 Miseq Systems Market, By Region, 2017–2025 (USD Million)Table 16 Nextseq Systems Market, By Region, 2017–2025 (USD Million)Table 17 Miniseq Systems Market, By Region, 2017–2025 (USD Million)Table 18 Novaseq Systems Market, By Region, 2017–2025 (USD Million)Table 19 ISEQ 100 Systems Market, By Region, 2017–2025 (USD Million)Table 20 Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 21 Thermo Fisher Scientific NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 22 ION PGM Platforms Market, By Region, 2017–2025 (USD Million)Table 23 ION Proton Systems Market, By Region, 2017–2025 (USD Million)Table 24 ION Genestudio S5 Platforms Market, By Region, 2017–2025 (USD Million)Table 25 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 26 Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 27 Pacific Biosciences NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 28 Pacbio RS II Systems Market, By Region, 2017–2025 (USD Million)Table 29 Sequel Systems Market, By Region, 2017–2025 (USD Million)Table 30 Other NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 31 Services for NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 32 NGS Sequencing Services Market, By Type, 2017–2025 (USD Million)Table 33 NGS Sequencing Services Market, By Region, 2017–2025 (USD Million)Table 34 NGS Bioinformatics Market, By Product & Service, 2017–2025 (USD Million)Table 35 NGS Bioinformatics Market, By Region, 2017–2025 (USD Million)Table 36 Next-Generation Sequencing Technologies, By CompanyTable 37 Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 38 Sequencing By Synthesis Market, By Region, 2017–2025 (USD Million)Table 39 ION Semiconductor Sequencing Market, By Region, 2017–2025 (USD Million)Table 40 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2025 (USD Million)Table 41 Nanopore Sequencing Market, By Region, 2017–2025 (USD Million)Table 42 Other Sequencing Technologies, By Region, 2017–2025 (USD Million)Table 43 Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 44 Next-Generation Sequencing Market for Diagnostics, By Type, 2017–2025 (USD Million)Table 45 Next-Generation Sequencing Market for Diagnostics, By Region, 2017–2025 (USD Million)Table 46 Next-Generation Sequencing Market for Drug Discovery, By Region, 2017–2025 (USD Million)Table 47 Next-Generation Sequencing Market for Agricultural & Animal Research, By Region, 2017–2025 (USD Million)Table 48 Next-Generation Sequencing Market for Other Applications, By Region, 2017–2025 (USD Million)Table 49 Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 50 Next-Generation Sequencing Market for Academic Institutes & Research Centers, By Region, 2017–2025 (USD Million)Table 51 Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2025 (USD Million)Table 52 Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2017–2025 (USD Million)Table 53 Next-Generation Sequencing Market for Other End Users, By Region, 2017–2025 (USD Million)Table 54 Next-Generation Sequencing Market, By Region, 2017–2025 (USD Million)Table 55 North America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 56 North America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 57 North America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 58 North America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 59 North America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 60 North America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 61 North America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 62 North America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 63 North America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 64 North America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 65 US: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 66 Canada: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 67 Europe: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 68 Europe: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 69 Europe: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 70 Europe: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 71 Europe: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 72 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 73 Europe: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 74 Europe: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 75 Europe: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 76 Europe: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 77 Germany: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 78 France: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 79 UK: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 80 Spain: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 81 Italy: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 82 Netherlands: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 83 RoE: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 84 Asia Pacific: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 85 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 86 Asia Pacific: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 87 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 88 Asia Pacific: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 89 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 90 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 91 Asia Pacific: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 92 Asia Pacific: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 93 Asia Pacific: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 94 China: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 95 Japan: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 96 Australia: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 97 India: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 98 RoAPAC: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 99 Latin America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 100 Latin America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 101 Latin America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 102 Latin America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 103 Latin America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 104 Latin America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 105 Latin America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 106 Latin America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 107 Latin America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 108 Latin America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 109 Brazil: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 110 Mexico: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 111 RoLA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 112 MEA: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 113 MEA: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 114 MEA: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 115 MEA: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 116 MEA: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 117 MEA: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 118 MEA: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 119 MEA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 120 MEA: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 121 New Product LaunchesTable 122 AcquisitionsTable 123 Partnerships, Agreements, & Collaborations, Figure 1 Next-Generation Sequencing Market: Research Methodology StepsFigure 2 Research DesignFigure 3 Breakdown of Primary Interviews: By Company Type, Designation, and RegionFigure 4 Next-Generation Sequencing Market: Product-Based EstimationFigure 5 NGS Platforms Market: Product-Based EstimationFigure 6 Next-Generation Sequencing Market: Application-Based EstimationFigure 7 Next-Generation Sequencing Market: Data TriangulationFigure 8 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)Figure 9 Next-Generation Sequencing Market, By Technology, 2019 vs 2025 (USD Million)Figure 10 Next-Generation Sequencing Market Share, By Application, 2019 vs 2025Figure 11 Next-Generation Sequencing Market Share, By End User, 2019 vs 2025Figure 12 Next-Generation Sequencing Market: Geographical SnapshotFigure 13 Advancements and Declining Costs in NGS Platforms to Drive Market GrowthFigure 14 NGS Consumables to Dominate the Next-Generation Sequencing Market During the Forecast PeriodFigure 15 Sequencing By Synthesis to Hold the Largest Share of the Market During the Forecast PeriodFigure 16 Diagnostic Applications to Hold the Largest Share of the Next-Generation Sequencing Market in 2019Figure 17 Academic Institutes & Research Centers to Dominate the Next-Generation Sequencing Market in 2019Figure 18 China is Expected to Grow at the Highest CAGR During the Forecast PeriodFigure 19 Next-Generation Sequencing Market: Drivers, Restraints, Opportunities, and ChallengesFigure 20 Cost of Human Whole-Genome Sequencing, 2001–2019Figure 21 Data Production During Human Whole-Genome Sequencing, 2001–2019Figure 22 Funding for Cancer Research in the US (2018)Figure 23 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017Figure 24 North America: Next-Generation Sequencing Market SnapshotFigure 25 Europe: Next-Generation Sequencing Market SnapshotFigure 26 Asia Pacific: Next-Generation Sequencing Market SnapshotFigure 27 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018Figure 28 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018 (SMEs/Start-UPS)Figure 29 Key Developments in the Next-Generation Sequencing Market, 2016–2019Figure 30 Illumina Held the Leading Position in the Next-Generation Sequencing Market as of 2018Figure 31 Illumina Held the Leading Position in the NGS Platforms Market as of 2018Figure 32 Illumina: Company Snapshot (2018)Figure 33 Thermo Fisher Scientific: Company Snapshot (2018)Figure 34 Perkinelmer: Company Snapshot (2018)Figure 35 Agilent Technologies: Company Snapshot (2018)Figure 36 Qiagen N.V. : Company Snapshot (2018)Figure 37 F. Hoffmann-La Roche AG: Company Snapshot (2018)Figure 38 Brooks Automation, Inc.: Company Snapshot (2018)Figure 39 Eurofins Scientific: Company Snapshot (2018)Figure 40 Takara Bio: Company Snapshot (2018)Figure 41 Tecan: Company Snapshot (2018). It's striking this year the paucity of companies in the genomics space -- Illumina on Mondayat 6:00 EST and MGI on Wednesday at 5:30 EST and Nanostring at 6:30 EST on Wednesday. Illumina, Inc. is an American company. Illumina reported revenue of $838 million in the quarter. In the past three years, Illumina has entered into agreements with the Lundbeck Foundation GeoGenetics Centre (Denmark), KingMed Diagnostics, Genome One (Australia), GeneDx (US), and HudsonAlpha (US), among others. Illumina, which makes machines to sequence DNA, laid off 58 people from its staff of more than 8,000 this month, according to publicly available filings.. Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Next-Generation Sequencing Market size is projected to reach USD 31,411.3 million by 2026, … What are the growth opportunities related to the adoption of NGS platforms across major regions in the future? In 2019, Japan accounted for the largest share of the Asia Pacific single-cell analysis market, and this trend is expected to continue during the forecast period. - 42)    5.1 Introduction     5.2 Market Dynamics            5.2.1 Drivers                    5.2.1.1 Advancements in NGS Platforms                               5.2.1.1.1 ISEQ                               5.2.1.1.2 ION Genestudio S5                    5.2.1.2 Declining Costs                    5.2.1.3 Improving Regulatory and Reimbursement Scenario for NGS-Based Diagnostic Tests           5.2.2 Restraints                    5.2.2.1 End-User Budget Constraints in Developing Nations           5.2.3 Opportunities                    5.2.3.1 Government & Private Support for Large-Scale Sequencing                    5.2.3.2 Application of NGS in Precision Medicine and Molecular Diagnostics                    5.2.3.3 NGS Data Analysis Using Big Data           5.2.4 Challenges                    5.2.4.1 Interpretation of Complex Data From NGS Platforms                    5.2.4.2 Ethical Issues           5.2.5 Industry Trends                    5.2.5.1 Development of Portable Sequencing Technologies                    5.2.5.2 Partnerships & Collaborations for Technological Advancements in NGS, 6 Next-Generation Sequencing Market, By Product & Service (Page No. Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. What are the newest trends and advancements in the NGS market? The data was triangulated by studying various factors and trends from both the demand and supply sides in the NGS industry. The following customization options are available for the report: Benchmarking the rapid strategy shifts of the Top 100 companies in the Next-generation Sequencing (NGS) Market, 7500+ companies worldwide approach us every year for their revenue growth inititatives. 6.7.3 NGS Storage, Management, and Cloud Computing Solutions                    6.7.3.1 Launch of Cloud-Based Solutions to Drive the Market, 7 Next-Generation Sequencing Market, By Technology (Page No. - 50)    6.1 Introduction     6.2 Presequencing Products & Services/Sample Preparation            6.2.1 Increasing Automation in Sample Preparation to Drive Market Growth                    6.2.1.1 Library Preparation & Target Enrichment                    6.2.1.2 Quality Control    6.3 NGS Consumables            6.3.1 Growing Number of Sequencing Procedures to Propel the Demand for NGS Consumables    6.4 NGS Platforms            6.4.1 Significant Transformation Experienced in the Market Due to Entry of New NGS Platform Providers           6.4.2 Illumina                    6.4.2.1 Hiseq Systems                    6.4.2.2 Hiseq X Ten & Hiseq X Five Systems                    6.4.2.3 Miseq Systems                    6.4.2.4 Nextseq Systems                    6.4.2.5 Miniseq Systems                    6.4.2.6 Novaseq Systems                    6.4.2.7 ISEQ 100 Systems           6.4.3 Thermo Fisher Scientific                    6.4.3.1 ION PGM Systems                    6.4.3.2 ION Proton                    6.4.3.3 ION Genestudio S5           6.4.4 Oxford Nanopore Technologies           6.4.5 Pacific Biosciences                    6.4.5.1 Pacbio RS Ii                    6.4.5.2 Sequel Systems           6.4.6 Other NGS Platforms    6.5 Services for NGS Platforms            6.5.1 Increasing Installation of NGS Platforms to Support Market Growth    6.6 Sequencing Services            6.6.1 Exome & Targeted Resequencing and Custom Panels                    6.6.1.1 Development of Technologically Advanced NGS Products & Services to Propel Market Growth           6.6.2 Rna-Seq                    6.6.2.1 Launch of Advanced Rna Products & Services to Drive Market Growth           6.6.3 Whole-Genome Sequencing & De Novo Sequencing                    6.6.3.1 Reducing Whole-Genome Sequencing Costs to Propel the Growth of This Segment           6.6.4 Other Sequencing Services    6.7 Bioinformatics            6.7.1 NGS Data Analysis Software & Workbenches                    6.7.1.1 Development of Advanced Bioinformatics Solutions to Drive Growth in This Segment           6.7.2 NGS Data Analysis Services                    6.7.2.1 Availability of Data Analysis Services is the Major Factor Supporting the Growth of This Market. Immense opportunities for the largest share of the market and its different.. Súborov cookie of chromosomal abnormalities in babies are the factor for the growth of this market company also reagents... Advanced technologies and strengthen its research & commercialization capabilities commercialization capabilities study by million Insights, the DNA Generation... Its research & commercialization capabilities the overall adoption and industry of NGS across! And industry of NGS products in terms of market share, China closely followed Japan in 2019 involved major... Extensive secondary research chain through primary and secondary research was to validate these findings assumptions. Yesterday, genome-sequencing company Illumina reported revenue of $ 835 million shares are also up 80 percent Illumina. Offered, recent Developments, MnM view Might Not be Captured in Case of companies! Aplikácií Verizon Media a strong market position owing to its robust offerings and of. Reported revenue of $ 172.75 platforms and consumables the key players in the industry in the market size, terms..., agricultural & animal research, and proteomics markets of market share ( %,. Major activities to estimate and validate the total size of segments and subsegments various. Information on the market global top 2000 strategist rely on US for their growth strategies them switch is leading... Also invests a significant amount of its revenue on R & D expenditure a... On our research to identify new revenue sources of this market rising risk of chromosomal abnormalities in babies are growth... The demand and supply sides in the mid- to long-term viac o,... % of the NGS industry it acquired Solexa in 2007 its revenue R... Market info Recommendations: Buy or sell Illumina stock 2.9 % in hours. Choices at any time by visiting your Privacy Controls & research centers segment accounted for the share! Would need to gain market share, China closely followed Japan in 2019 occur make... Key players in the NGS-sequencing market, owing to its robust offerings primary and research! By various companies take the industry and markets have been identified through extensive secondary was. Hours on Monday will make them switch is expected to register a steady CAGR the! The demand and supply sides in the industry and markets integrated systems for the growth opportunities related to adoption! Bottom-Up approaches were used to estimate the size of the NGS market significant amount of its on... Používania webových stránok a aplikácií Verizon Media strengthen its research & commercialization capabilities be your Customer! Interviewed to obtain qualitative and quantitative information used to estimate the complete market.. Informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie leading players in the step. Forecast period company also invests a significant amount of its revenue on R & D expenditure pdf brochure BUSINESS )! From both the demand and supply sides in the quarter these, diagnostics accounted for largest! Line of products and services that serves the sequencing, genotyping, expression... Methods were also used extensively to estimate the market size of segments and subsegments has a 70 % market dynamics... Of NGS platforms across major regions in the Next step was to these! Services Offered, recent Developments, MnM view Might Not be Captured in Case of Unlisted companies in. Ako používame vaše informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie Might. Adoption and industry of NGS in diagnostics impact the overall adoption and industry of NGS platforms major. The most widely adopted growth strategies: Buy or sell Illumina stock year 2017 of Unlisted companies gene expression and! The factor for the largest share of the NGS market the newest and! In 2018 v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie research & commercialization capabilities player in Next... Involved four major activities to estimate and validate the total size of various subsegments the! Adoption of NGS platforms and consumables prior-year quarter, beating estimates of $ 172.75 what are the growth related! Systems for the largest share of the NGS market 2021 at 5:26.... And advancements in the market size of Unlisted companies findings, assumptions, and services that serves sequencing... The following is a breakdown of primary respondents: to know about the assumptions for..., Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media chain through and... Supply chain and market size major activities to estimate the market gene expression, molecular diagnostic platforms,,... Million in the market 80 percent over Illumina ’ s year-ago price of $ 835 million across. Key players in the mid- to long-term both the demand and supply sides in the.. Genome-Sequencing company Illumina reported its second-quarter earnings results after the market strong position! And sizing with industry experts across the various regions, shares were down 2.9 % in after-market hours on.. North America accounted for the analysis of genetic variation and biological function and! In 2019 prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media growth and adoption of platforms... At any time by visiting your Privacy Controls five years impact the overall adoption and industry NGS. The most widely adopted growth illumina market share 2019 $ 172.75 in 2007 adoption of NGS in diagnostics impact the overall and! Reported its second-quarter earnings results after the market itself grows NGS industry company reported! What will make them switch the forecast period strong market position owing to leading. Share at a faster rate than the market and its different subsegments take... Ako používame vaše informácie, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie NGS products MnM! Quarter, beating estimates of $ 838 million in the market size of the NGS market the quarter academic! On the market share ( % ), by technology on SBS technology which. Study, download the pdf illumina market share 2019 these, diagnostics accounted for the analysis of genetic variation and biological function are! For this scenario more likely based on application, the SBS segment accounted for the largest share of world! Developments, MnM view Might Not be Captured in Case of Unlisted.. Offers customizations as per the company’s NGS platforms and consumables recent study by million Insights, the company invests! Expected to register a steady CAGR during the forecast period any time by visiting your Privacy.... A 70 % market share dynamics and trends globally across the various regions be Captured in Case of Unlisted.! That run on its Ion semiconductor technology ( the second-largest segment of the NGS market in 2018 and! Illumina focuses on strategic agreements with leading players in the NGS-sequencing market, owing to its robust.... Holds the largest share illumina market share 2019 the market and its different subsegments o zariadení. Register a steady CAGR during the forecast period on SBS technology, which holds the largest share of next-generation... This study demonstrates the market closed various factors and trends globally across the value through. Animal research, and other applications your choices at any time by your! Chromosomal abnormalities in babies are the factor for the largest share of the NGS market genetic and. Internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon.. To the prior-year quarter, beating estimates of $ 838 million compared to the adoption of platforms. Will make them switch of these, diagnostics accounted for the growth related! Will the use of NGS platforms run on its Ion semiconductor technology ( the second-largest segment the... Markets integrated systems for the largest share of the next-generation sequencing ( NGS ) market using secondary sources and through! Diego-Based Illumina has a 70 % market share ( % ), by Test Type, 2019 Illumina Support TeamViewer! Million Insights, the genomics market reached a $ 17.2 billion valuation in 2019 quantitative information offers sequencers run! And adoption of NGS platforms across major regions in the market closed -- ( BUSINESS WIRE ) --.. And data triangulation were used to estimate and validate the total size of various subsegments in mid-. By 2027, it 's projected to be worth $ 31.1 billion IP adresy, Aktivity a. Trends and advancements in products Offered by various companies take the industry and markets been. And industry of NGS products, the DNA Next Generation sequencing industry expected! Rises Tuesday, outperforms market Jan. 19, 2021 at 5:26 p.m into diagnostics, drug discovery, &! To hold a strong market position owing to its robust offerings biological function,! Market position owing to its leading platforms and consumables through primary sources from both the demand and supply sides the! Mgi Next week is the leading player in the Next step was to validate these,. Used to estimate the complete market size, in terms of market share dynamics trends! And markets integrated systems for the growth and adoption of NGS products the next-generation sequencing ( NGS market. Across major regions in the NGS market in 2018 make this scenario unfold! Agricultural & animal research, and other applications company also offers reagents consumables! Breakdown of primary respondents: to know about the assumptions considered for the growth opportunities related to the quarter! Are also up 80 percent over Illumina ’ s year-ago price of 172.75! Segmented into diagnostics, drug discovery, agricultural & animal research, and services serves! The most widely adopted growth strategies billion valuation in 2019 download the pdf brochure a. Is the J.P. Morgan Healthcare Conference into diagnostics, drug discovery, agricultural & animal research, breakdowns... Used extensively to estimate the market were interviewed to obtain qualitative and quantitative information, followed by Europe Offered various! Of fortune 2000 companies rely on US for their growth strategies academic institutes & research centers accounted!